financetom
Business
financetom
/
Business
/
Campbell's lowers full-year forecasts on weak demand
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Campbell's lowers full-year forecasts on weak demand
Mar 5, 2025 4:42 AM

(Reuters) - Campbell's Co lowered its annual sales and profit forecasts on Wednesday, signaling weak demand for snacks amid intense competition from cheaper private-label brands.

The company's shares were down about 4% to $39 before the bell.

Consumer packaged food firms such as Campbell's and PepsiCo have seen cautious spending from customers, particularly related to snacking, against the backdrop of repeated price hikes over the past year.

The company now expects fiscal 2025 net sales to rise between 6% and 8%, compared with its previous forecast range of 9% to 11% growth.

The revised forecast does not reflect any impact from the potential import tariffs by the U.S. government and potential retaliatory tariffs taken by other countries, Campbell's said.

"Given the softness in some of our snacking categories, the anticipated sequential top line improvement did not materialize during the quarter, and now we have a more muted second half expectation," Campbell's CEO Mick Beekhuizen said.

Indications from recent economic data such as retail sales and consumer confidence have sparked worries of a slowing economy.

Campbell's lowered its adjusted profit per share forecast to between $2.95 and $3.05, from prior expectations of $3.12 to $3.22.

For the quarter ended January 26, the company's net sales rose 9% to $2.69 billion, compared with the average analyst estimate of $2.74 billion, according to data compiled by LSEG.

On an adjusted basis, Campbell's earned 74 cents per share, compared with estimates of 72 cents.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Comcast tops revenue expectations on Olympics ad boost, blockbuster releases
Comcast tops revenue expectations on Olympics ad boost, blockbuster releases
Nov 3, 2024
(Reuters) -Comcast ( CMCSA ) beat third-quarter revenue estimates on Thursday, driven by strong box office performance for its studio, higher ad sales during the 2024 Paris Olympics and a smaller-than-expected decline in broadband subscribers. Shares of the company rose 4.2% in premarket trading. The company's media business saw a $1.9 billion revenue boost from the Paris Games, its highest-ever...
BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement
BRIEF-Aerovate Therapeutics And Jade Biosciences Announce Merger Agreement
Nov 3, 2024
Oct 31 (Reuters) - Aerovate Therapeutics Inc ( AVTE ): * AEROVATE THERAPEUTICS AND JADE BIOSCIENCES ANNOUNCE MERGER AGREEMENT * AEROVATE THERAPEUTICS INC ( AVTE ) - JADE SECURES $300 MILLION IN PRIVATE INVESTMENT * AEROVATE THERAPEUTICS INC ( AVTE ) - STOCKHOLDERS TO OWN 1.6% OF COMBINED COMPANY * AEROVATE THERAPEUTICS INC ( AVTE ) - TOM FROHLICH TO...
Entergy's Q3 Adjusted Earnings Decline; Raises Lower End of Fiscal 2024 Adjusted EPS Guidance
Entergy's Q3 Adjusted Earnings Decline; Raises Lower End of Fiscal 2024 Adjusted EPS Guidance
Nov 3, 2024
07:11 AM EDT, 10/31/2024 (MT Newswires) -- Entergy ( ETR ) reported Q3 adjusted earnings Thursday of $2.99 per share, down from $3.27 a year earlier. Analysts polled by Capital IQ expected $2.99. The company said it now expects fiscal 2024 adjusted EPS of $7.15 to $7.35. That compares with its previous forecast of $7.05 to $7.35. Analysts polled by...
Regeneron Pharmaceuticals' Q3 Adjusted Net Income, Revenue Rises
Regeneron Pharmaceuticals' Q3 Adjusted Net Income, Revenue Rises
Nov 3, 2024
07:13 AM EDT, 10/31/2024 (MT Newswires) -- Regeneron Pharmaceuticals ( REGN ) reported Q3 non-GAAP net income Thursday of $12.46 per diluted share, up from $11.59 a year earlier. Analysts polled by Capital IQ expected $11.71. Total revenue for the quarter ended Sept. 30 was $3.72 billion, up from $3.36 billion a year earlier. Analysts surveyed by Capital IQ expected...
Copyright 2023-2026 - www.financetom.com All Rights Reserved